» Articles » PMID: 28451298

Enrichment and Single-cell Analysis of Circulating Tumor Cells

Overview
Journal Chem Sci
Specialty Chemistry
Date 2017 Apr 29
PMID 28451298
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Up to 90% of cancer-related deaths are caused by metastatic cancer. Circulating tumor cells (CTCs), a type of cancer cell that spreads through the blood after detaching from a solid tumor, are essential for the establishment of distant metastasis for a given cancer. As a new type of liquid biopsy, analysis of CTCs offers the possibility to avoid invasive tissue biopsy procedures with practical implications for diagnostics. The fundamental challenges of analyzing and profiling CTCs are the extremely low abundances of CTCs in the blood and the intrinsic heterogeneity of CTCs. Various technologies have been proposed for the enrichment and single-cell analysis of CTCs. This review aims to provide in-depth insights into CTC analysis, including various techniques for isolation of CTCs with capture methods based on physical and biochemical principles, and single-cell analysis of CTCs at the genomic, proteomic and phenotypic level, as well as current developmental trends and promising research directions.

Citing Articles

Label-Free and Rapid Microfluidic Design Rules for Circulating Tumor Cell Enrichment and Isolation: A Review and Simulation Analysis.

Mansor M, Yang C, Chong K, Jamrus M, Liu K, Yu M ACS Omega. 2025; 10(7):6306-6322.

PMID: 40028152 PMC: 11866005. DOI: 10.1021/acsomega.4c08606.


Role of Cell Adhesion in Cancer Metastasis Formation: A Review.

Burcik D, Macko J, Podrojkova N, Demeterova J, Stano M, Orinak A ACS Omega. 2025; 10(6):5193-5213.

PMID: 39989825 PMC: 11840620. DOI: 10.1021/acsomega.4c08140.


Digital Microfluidics for Sample Preparation in Low-Input Proteomics.

Steinbach M, Leipert J, Matzanke T, Tholey A Small Methods. 2024; 9(1):e2400495.

PMID: 39205538 PMC: 11740955. DOI: 10.1002/smtd.202400495.


Harnessing virus flexibility to selectively capture and profile rare circulating target cells for precise cancer subtyping.

Li H, Chen Y, Li Y, Wei X, Wang S, Cao Y Nat Commun. 2024; 15(1):5849.

PMID: 38992001 PMC: 11239949. DOI: 10.1038/s41467-024-50064-y.


Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells.

Kotsifaki A, Maroulaki S, Armakolas A Int J Mol Sci. 2024; 25(9).

PMID: 38732051 PMC: 11084220. DOI: 10.3390/ijms25094832.


References
1.
Marusyk A, Polyak K . Tumor heterogeneity: causes and consequences. Biochim Biophys Acta. 2009; 1805(1):105-17. PMC: 2814927. DOI: 10.1016/j.bbcan.2009.11.002. View

2.
Sun N, Wang J, Ji L, Hong S, Dong J, Guo Y . A Cellular Compatible Chitosan Nanoparticle Surface for Isolation and In Situ Culture of Rare Number CTCs. Small. 2015; 11(40):5444-51. DOI: 10.1002/smll.201501718. View

3.
Gascoyne P, Noshari J, Anderson T, Becker F . Isolation of rare cells from cell mixtures by dielectrophoresis. Electrophoresis. 2009; 30(8):1388-98. PMC: 3754902. DOI: 10.1002/elps.200800373. View

4.
Heath J, Ribas A, Mischel P . Single-cell analysis tools for drug discovery and development. Nat Rev Drug Discov. 2015; 15(3):204-16. PMC: 4883669. DOI: 10.1038/nrd.2015.16. View

5.
Myung J, Gajjar K, Saric J, Eddington D, Hong S . Dendrimer-mediated multivalent binding for the enhanced capture of tumor cells. Angew Chem Int Ed Engl. 2011; 50(49):11769-72. PMC: 3549433. DOI: 10.1002/anie.201105508. View